Biaoru Li. (2017) THERAPEUTIC TARGETING OF TUMORIGENESIS AND TUMOR DISEASE -FOR CLINICAL ANALYSIS OF EPIGENETICS AND EPIGENOME. International Journal of Hematology and Therapy 3:1, pages 1-12.
Crossref
H. Joachim Deeg, David T. Bowen, Steven D. Gore, Torsten Haferlach, Michelle M. Le Beau & Charlotte NiemeyerHarold J. Olney & Michelle M. Le Beau. 2013. Myelodysplastic Syndromes. Myelodysplastic Syndromes
41
72
.
Moshe Mittelman, Howard S. Oster, Michael Hoffman & Drorit Neumann. (2010) The lower risk MDS patient at risk of rapid progression. Leukemia Research 34:12, pages 1551-1555.
Crossref
. 2010. Cancer Cytogenetics. Cancer Cytogenetics
141
178
.
H. Ohyashiki Junko & Ohyashiki Kazuma. 2009. Telomeres and Telomerase in Cancer. Telomeres and Telomerase in Cancer
211
224
.
Mark W. Drummond, Stefan Balabanov, Tessa L. Holyoake & Tim H. Brummendorf. (2007) Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells. Stem Cells 25:8, pages 1853-1861.
Crossref
Thomas A. Widmann, Markus Herrmann, Naim Taha, Jochem König & Michael Pfreundschuh. (2007) Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Experimental Hematology 35:6, pages 939-946.
Crossref
T H Brümmendorf & S Balabanov. (2006) Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover. Leukemia 20:10, pages 1706-1716.
Crossref
H. J. Deeg, D. T. Bowen, S. D. Gore, T. Haferlach, M. M. Le Beau & C. NiemeyerHarold J. Olney & Michelle M. Le Beau. 2006. Hematologic Malignancies: Myelodysplastic Syndromes. Hematologic Malignancies: Myelodysplastic Syndromes
55
79
.
Harold J. Olney & Michelle M. Le Beau. 2009. Myelodysplastic Syndromes. Myelodysplastic Syndromes
95
128
.
A Röth, S Vercauteren, H J Sutherland & P M Lansdorp. (2003) Telomerase is limiting the growth of acute myeloid leukemia cells. Leukemia 17:12, pages 2410-2417.
Crossref
Betty Gladstone, Smitha Sivaraman, Naomi Galili, Parameswaran Venugopal, Imke Janssen, Jaya Nayini, Jie Yang, Wei-Tong Hsu, Azra Raza & Harvey D. Preisler. (2003) A novel method for single cell detection of in situ telomerase or histone H3 in combination with clonal analysis by FISH. Leukemia Research 27:6, pages 529-537.
Crossref
Srdan Verstovsek, Taghi Manshouri, Franklin O. Smith, Francis J. Giles, Jorge Cortes, Elihu Estey, Hagop Kantarjian, Michael Keating, Sima Jeha & Maher Albitar. (2003) Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia. Cancer 97:9, pages 2212-2217.
Crossref
S Franco, M F Ozkaynak, C Sandoval, O Tugal, S Jayabose, M Engelhardt & M A S Moore. (2003) Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Leukemia 17:2, pages 401-410.
Crossref
Junko H. Ohyashiki, Goro Sashida, Tsutomu Shichishima & Kazuma Ohyashiki. 2003. Paroxysmal Nocturnal Hemoglobinuria and Related Disorders. Paroxysmal Nocturnal Hemoglobinuria and Related Disorders
167
178
.
Junko H Ohyashiki, Goro Sashida, Tetsuzo Tauchi & Kazuma Ohyashiki. (2002) Telomeres and telomerase in hematologic neoplasia. Oncogene 21:4, pages 680-687.
Crossref
Francesco D. Pisani & Angela Rainaldi. (2001) Management of high-risk myelodysplastic syndromes. Critical Reviews in Oncology/Hematology 40:3, pages 215-228.
Crossref
Rose Ann Padua, Angela McGlynn & Hugh McGlynn. 2001. Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia. Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia
111
157
.
Harvey D. Preisler. 2001. Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia. Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia
185
230
.